文献速递临床试验与 GCP真实世界研究与卫生经济

紫外线传感器可穿戴设备干预改善黑色素瘤幸存者防晒行为并减少晒伤:平行组随机对照试验研究方案

UVR-sensor wearable device intervention to improve sun behaviors and reduce sunburns in melanoma survivors: study protocol of a parallel-group randomized controlled trial.
PubMed 文献 · Trials · 2020-11-23

本研究为平行组随机对照试验,计划纳入368名黑色素瘤幸存者,分两波(2020年夏、2021年夏)开展。干预组使用紫外线辐射传感器可穿戴设备及配套应用,提供实时提醒;对照组使用无提醒功能的设备。主要比较12周干预后防晒习惯总结指标和晒伤经历,并评估身体活动、抑郁和焦虑等潜在非预期效应。

要点

  • 黑色素瘤幸存者发生新原发黑色素瘤风险增高,防晒行为可优化。
  • 紫外线传感器可穿戴设备联合手机应用提供实时提醒以促进防晒。
  • 研究将评估干预对防晒习惯和晒伤的影响及潜在非预期效应。

核心结论

  • 该研究方案旨在评估紫外线传感器可穿戴设备能否改善黑色素瘤幸存者的防晒行为并减少晒伤。

研究设计与样本

  • 平行组随机对照试验,计划纳入368名黑色素瘤幸存者,分两波(2020年夏和2021年夏)招募。
  • 干预组接受防晒行为信息手册和商用紫外线传感器可穿戴设备(Shade)及配套手机应用,对照组接受设备和无提醒功能的独立应用。
  • 参与者需佩戴设备12周,在研究开始时、干预期间每4周及1年后完成防晒行为调查。

关键数值与推荐

  • 主要比较干预结束时干预组与对照组在防晒习惯总结指标和晒伤经历上的差异。
  • 同时测量自我报告的身体活动、抑郁和焦虑以考察潜在非预期负性后果。

临床怎么用

  • 若干预有效,可支持将该技术扩展用于其他黑色素瘤高风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals who have been diagnosed with melanoma have more than a 9-fold increased risk of developing another melanoma. Ultraviolet radiation (UVR) exposure following a melanoma diagnosis can be modified to reduce risk of a new melanoma diagnosis. Yet research shows that many melanoma survivors do not report optimal sun protection practices. The objective of this study is to evaluate the effectiveness of a UVR-sensor wearable device to improve sun protection behaviors and reduce sunburns in a randomized controlled trial (RCT) in melanoma survivors. METHODS: We will conduct an RCT among 368 melanoma survivors in two waves (Summer 2020, Summer 2021). This approach allows for adequate recruitment of the required sample and potential improvements to recruitment, compliance, and retention strategies between waves. The intervention includes an informational brochure about sun protection behaviors and a commercially available UVR-sensor wearable device (Shade), which accurately measures UVR. The device, along with its associated mobile application, measures and stores UVR exposure. As UVR exposure accumulates, the device provides notifications to increase sun protection action. Survivors in the control group receive the device and a separate mobile application that does not provide notifications or summary UVR exposure data. Participants will be asked to wear the device for 12 weeks. They will complete surveys about their sun behaviors at study entry, every 4 weeks during the intervention, and 1 year later. At the end of the intervention period, intervention and control groups will be compared for differences in a summary measure of sun protection habits and experience of a sunburn. We will also measure self-reported physical activity, depression, and anxiety to examine potential unintended negative consequences of the intervention. DISCUSSION: The study intervention will be completed Fall 2021, with anticipated results available in 2022. If this intervention improves sun protection behaviors in melanoma survivors, these findings would support expanding the use of this technology with other populations at high risk for melanoma. TRIAL REGISTRATION: ClinicalTrials.gov NCT03927742 . Registered on April 15, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Vogel RI, Nagler RH, Ahmed RL, et al. UVR-sensor wearable device intervention to improve sun behaviors and reduce sunburns in melanoma survivors: study protocol of a parallel-group randomized controlled trial. Trials. 2020. PMID: 33228807. doi:10.1186/s13063-020-04881-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。